Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survival

por Fromigue, O, Kheddoumi, N, Body, J-J
Publicado 2003

Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance

por Habel, N, Hamidouche, Z, Girault, I, Patiño-García, A, Lecanda, F, Marie, P J, Fromigué, O
Publicado 2013